Prostate cancer: Prevalence and treatment in African men. JMHG 2005; 2(4): 400-405Heyns C, Lecuona A and Trollip G. Prostate cancer: prevalence and treatment in African Men. J Mens Health Gend 2005; 2(4): 400-405.Heyns CF, Lecuona AT, Trollip GS. Prostate cancer: Prevalence and ...
Prostate cancer is a potential men's health problem. The prevalence of prostate cancer continues to rise. Serum PSA (Prostate Specific Antigen) can be used as a screening tool for detection of early prostate cancer However, a screening program for prostate cancer has not yet been accepted as ...
The prevalence of prostate cancer was 6.6 percent among men with a PSA level of up to 0.5 ng per milliliter, 10.1 percent among those with values of 0.6 to 1.0 ng per milliliter, 17.0 percent among those with values of 1.1 to 2.0 ng per milliliter, 23.9 percent among those with ...
1. National Cancer Institute. Cancer stat facts: prostate cancer. https://seer.cancer.gov/statfacts/html/prost.html. Accessed March 8, 2018. 2. Jahn JL, Giovannucci EL, Stampfer MJ. The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of ...
Prevalence of Prostate Cancer Among Men with Normal PSA LevelsProstate CancerNew England Journal of Medicine
8. 2021年10月18日,武汉大学曾宪涛副教授团队在The prostate上发表论文“Spatial and temporal patterns of prostate cancer burden and their association with Socio-Demographic Index in Asia, 1990-2019”,就亚洲前列腺癌疾病负担的时空分布特征进行了探讨。
The prevalence of prostate cancer seems to be the highest in Australia, New Zealand, North America and western and northern Europe, primarily because the practice of getting tested for prostate cancer is far more common in those parts of the world than it is elsewhere, according to the WHO. ...
Introduction Prostate cancer is a leading cause of death in men, but despite its prevalence, its cause remains unclear in most men. Inherited mutations have considerable implications at presentation for staging,1 screening,2 treatment,3 genetic counseling, and cascade testing of family members.4 Howe...
Fig. 2: Prevalence of driver gene mutations in localized and metastatic prostate cancer. AThe proportion of tumors harboring each driver mutation in localized prostate cancer or mCRPC (‘Observed Δ Proportion’), as described. Dot size indicates −log10q-value; dot color indicates driver mutation...
Histologic grading of prostate cancer: a perspective. Hum Pathol. 1992;23(3):273-279.PubMedGoogle ScholarCrossref 25. Polednak AP. Estimating the number of US incident cancers attributable to obesity and the impact on temporal trends in incidence rates for obesity-related cancers. Cancer ...